Entering text into the input field will update the search result below

Morphic Holding, Inc. (MORF) CEO Praveen Tipirneni on Q4 2020 Results - Earnings Call Transcript

Mar. 01, 2021 2:28 PM ETMorphic Holding, Inc. (MORF) Stock
SA Transcripts profile picture
SA Transcripts

Morphic Holding, Inc. (NASDAQ:MORF) Q4 2020 Earnings Conference Call March 1, 2021 8:00 AM ET

Company Participants

Chris Erdman - Senior Vice President of Communications

Praveen Tipirneni - Chief Executive Officer

Marc Schegerin - Chief Operating Officer and Chief Financial Officer

Bruce Rogers - Chief Scientific Officer

Peter Linde - Chief Medical Officer

Conference Call Participants

Michael Yee - Jefferies

Gregory Renza - RBC Capital Markets

Do Kim - BMO Capital Markets

Ritu Baral - Cowen

Yasmeen Rahimi - Piper Sandler

Matt Phipps - William Blair


Excuse me ladies and gentlemen, this is the operator. My name is [Myra]. Thank you for standing by and welcome to the Morphic Financial and Operational Results 2020 Year-End Conference Call. At this time, all participants are in listen-only mode. After the speaker presentation, there will be a question-and-answer session. [Operator Instructions]

With that I would now like to hand the conference over to our first speaker, Chris Erdman, Senior Vice President of Communications. Thank you. And please go ahead.

Chris Erdman

Thank you, [Maya], and good morning, everyone. Thanks for attending Morphic’s first investor call. Today we will review our 2020 operational and financial results and also provide an update on the ongoing Phase 1 clinical trial of MORF-057. A little housekeeping. This morning, we issued two press releases. The first reported results for the fourth quarter and full-year ended December 31, 2020. And the second announced the preliminary positive results from the single ascending dose portion of our ongoing Phase 1 trial MORF-457. These releases, as well as our most recent corporate presentations are available on the investor section of our website at morphictx.com.

Also, before we begin, please note that we will be making forward-looking statements as defined in the Private Securities Litigation Act of 1995. These statements will include among other things, projections

Recommended For You


To report an error in this transcript, .Contact us to add your company to our coverage or use transcripts in your business. Learn more about Seeking Alpha transcripts here. Your feedback matters to us!

About MORF

SymbolLast Price% Chg
Market Cap
Yield (TTM)
Rev Growth (YoY)
Short Interest
Prev. Close
Compare to Peers

More on MORF

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.